Business Wire

New Airship Preference Center Gives Marketers Full Control to Retain Consumer Opt-ins Without Ongoing Developer Support Ahead of Changes to iOS 15 Notifications

23.9.2021 16:00:00 EEST | Business Wire | Press release

Share

Apple’s newly introduced iOS 15 gives consumers greater control over how, when and where notifications arrive on their phone. If these new features are broadly adopted, current practices for notifications may not light up smartphone screens to immediately alert users. Since most iPhones will soon be running on iOS 15, it’s imperative that brands optimize their mobile engagement strategies to better serve their valuable app audiences with individualized preferences and exceptional, real-time experiences.

In order to accelerate brands’ efforts, customer engagement company Airship today announced the availability of Airship Preference Center — the industry’s first marketer-friendly preference center that makes it simple to create, manage and optimize customers’ opt-in choices without ongoing developer support or requisite app updates for the App Store or Google Play.

In addition to Airship Preference Center, the company’s day-one support for iOS 15 allows marketers to specify interruption levels for notifications — Passive, Active, Time Sensitive, or Critical — which iOS 15 uses to determine how they will be delivered. For example, a notification can be set to break through a ‘Focus’ mode to immediately alert a user, or it can be selected to arrive with an audible alert or not. Marketers can also use Airship to set relevance scores for notifications and to add rich media, which alongside user behavior, sets the order and prominence of a brand’s messages within the user-scheduled Notifications Summary.

“Mobile apps have been a lifeline for both businesses and consumers throughout the pandemic, offering faster purchasing, richer content and streamlined conveniences like curbside pickup. However, new user-centric notification controls mean marketers must be much clearer and more precise in the preference choices offered to customers to ensure the communications they receive are relevant and valued,” said Brett Caine, CEO and president, Airship. “Airship Preference Center brings unparalleled speed and flexibility to understand individual customer preferences, and fine-tune the experience with the full power of our platform to reach people when and where it matters most to them.”

Airship Preference Center is seamlessly integrated within Airship’s SaaS Customer Engagement Platform, enabling marketers to easily guide customers to their preference center through contextually triggered in-app messages or any number of cross-channel journeys for onboarding, loyalty enrollment, new subscription content and more. Airship’s easy-to-use composer enables marketers to quickly create multiple subscription lists spanning popular interests, topics or types of messages without the need for developer support.

For example, marketing messages like sales events and flash deals, or transactional messages like monthly statements or delivery/curbside pickup alerts, provide a range of urgency and convenience that expands consumer choice and improves long term opt-in retention as customers get what they want on each mobile channel. Marketers can automate combining opt-in selections with customers’ real-time mobile behaviors for hyper-personalized messaging. It’s also easy to track list opt-ins or review in-depth Performance Analytics reports to continually fine-tune and enhance options offered to customers.

“As pandemic restrictions lift and broad-scale travel resumes it’s absolutely vital that we connect our customers to the best values and broader inspiration to satisfy pent-up wanderlust,” said Dave McCormick, Managing Director - Product & Design, Alaska Airlines. “Airship’s Preference Center will provide an easy and efficient way to ensure marketing messages do not diminish the role our mobile app plays as a real-time travel companion, notifying customers of when they can check-in or if there happens to be a gate change.”

Register for Elevate 2021, a virtual global forum for marketers and mobile product owners, taking place October 27-28, 2021. Attendees will learn about mobile-first best practices and insights driving innovation, business growth and deeper customer connections for dozens of leading brands around the world.

Airship in Independent Industry Analyst Evaluations

Airship was recently named a Leader in “The Forrester Wave™: Mobile Engagement Automation, Q3 2020,” receiving the highest score in the Strategy category and the second highest score in the Current Offering category.

Also, for the second consecutive year, Airship was positioned highest in its ability to execute and also furthest for its completeness of vision in Gartner’s 2020 Magic Quadrant for Mobile Marketing Platforms 1, and received the highest Product Scores across all three Use Cases in Gartner’s 2020 Critical Capabilities for Mobile Marketing Platforms 2, including the Acquisition, Engagement and Retention Use Cases.

1Gartner “Magic Quadrant for Mobile Marketing Platforms” by Mike McGuire, Anna Maria Virzi, Joseph Enever, October 26, 2020

2Gartner “Critical Capabilities for Mobile Marketing Platforms” by Mike McGuire, Anna Maria Virzi, Joseph Enever, October 29, 2020

Gartner Disclosure

Gartner does not endorse any vendor, product or service depicted in its research publications, and does not advise technology users to select only those vendors with the highest ratings or other designation. Gartner research publications consist of the opinions of Gartner’s research organization and should not be construed as statements of fact. Gartner disclaims all warranties, expressed or implied, with respect to this research, including any warranties of merchantability or fitness for a particular purpose.

About Airship

Thousands of the world’s leading brands rely on Airship to spark exceptional experiences with their customers through highly contextual and relevant interactions. Only Airship’s SaaS Customer Engagement Platform takes a mobile-first, data-led approach that enables brands to focus on individuals and their needs, rather than which marketing channels to use. Airship makes it much simpler and more effective to grow customer lifetime value in the omnichannel era.

With trillions of interactions intelligently orchestrated across mobile apps, mobile wallet, SMS, websites, and email, Airship optimizes the entire customer journey across all digital touchpoints at scale.

For more information, visit www.airship.com, read our blog or follow us on Twitter, LinkedIn and Facebook.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

North America:
Corey Gault
Airship
+1 503-206-9164
corey@airship.com

Kristen Caron
Aircover Communications
978-407-9283
kristen.caron@aircoverpr.com

Europe:
Ana Williams
Airship
+44 (0)20 3405 5160
Ana.Williams@airship.com

UK:
Pauline Delorme
Tyto PR
+44 7531642983
pauline.delorme@tytopr.com
Airship@tytopr.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

From Network Automation to Agentic NetOps: NetBrain Sets the Standard for Deploying AI in Network Operations29.5.2026 16:00:00 EEST | Press release

NetBrain Technologies, Inc. today announced major new platform features that advance Agentic NetOps from an emerging category to operational reality. NetBrain's clients are already deploying agents that are diagnosing and remediating issues across complex multi-vendor enterprise networks. These new features further extend the platform with new agent tooling, cross-domain context, and open interfaces for the broader agentic enterprise. Early customer outcomes show the magnitude of the shift: A leading health insurer used NetBrain's Deep Diagnosis agent to diagnose and resolve a weeks old VPN connectivity issue in under five minutes. A large manufacturer resolved a critical device issue with a single prompt, isolating the root cause across the network path in under 20 minutes, saving hundreds of hours of engineer time, shrinking MTTR by more than 95%. A global telecommunications firm found NetBrain's context-grounded agents outperformed a stand-alone frontier LLM on a persistent firewall

Adtran resolves long-running patent litigation, reinforcing commitment to defend innovation29.5.2026 15:00:00 EEST | Press release

Adtran today announced it has resolved a patent litigation matter, resulting in a full settlement and dismissal of all claims with prejudice. The case, initiated in 2020 by a non-practicing entity asserting five patents, was transferred to the US District Court for the Northern District of Alabama in 2021 following a successful motion by Adtran. Adtran subsequently filed counterclaims, including bad-faith patent assertion under Alabama statutory law. The settlement includes payment to Adtran to resolve its counterclaims. Terms of the agreement remain confidential. “This outcome reflects a disciplined and consistent approach to protecting our innovation and our customers,” said Justin Ferguson, SVP and general counsel at Adtran. “We take all claims seriously, but we will not hesitate to defend ourselves when assertions lack merit. Situations like this place unnecessary strain on technology providers and divert resources from advancing networks and services. By advancing our counterclaim

Meiji Seika Pharma Invests in GHIC’s Global Health Security Fund29.5.2026 14:00:00 EEST | Press release

Meiji Seika Pharma Co., Ltd. (Headquarters: Tokyo, Japan; President and Representative Director: Toshiaki Nagasato) today announced that it has committed to invest in the Global Health Security Fund (GHSF), which is sponsored by Global Health Investment Corporation (GHIC), a New York-based nonprofit organization. Through this investment, Meiji Seika Pharma will support the acceleration of innovations addressing critical global health challenges, including pandemic preparedness and antimicrobial resistance (AMR). GHIC is a mission‑driven nonprofit organization that deploys private investment strategies to generate both global health impact and financial returns. GHIC recently closed its second fund in GHSF. With more than a decade of experience investing in the field of infectious disease, GHIC has contributed to addressing major global health challenges. Its portfolio companies have successfully commercialized more than a dozen products, collectively reaching over 600 million people wo

IFF Enters Into Agreement to Sell Its Food Ingredients Business to CVC29.5.2026 13:50:00 EEST | Press release

IFF (NYSE: IFF), a global leader in flavors, fragrances, food ingredients, and health and biosciences, today announced that it has entered into an agreement to sell its Food Ingredients business to funds advised by CVC Capital Partners, a leading global private markets manager, in a transaction that values the business at approximately $4.3 billion, representing an enterprise value-to-EBITDA multiple of approximately 10x. As part of the transaction, IFF has chosen to retain an approximately 10% minority equity interest in the business, or approximately $200 million, permitting continued collaboration and cooperation between IFF and Food Ingredients and allowing IFF and its shareholders to participate in future value creation under its new ownership. The transaction marks a significant step in IFF’s portfolio transformation and is expected to strengthen the company’s focus on its innovation-driven businesses: Taste, Scent, and Health & Biosciences. Following the transaction, IFF will be

BeOne Medicines Establishes Standard for Long-Term Disease Control in CLL with BRUKINSA 78-Month Data at ASCO 202629.5.2026 13:00:00 EEST | Press release

BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, is advancing the treatment paradigm in chronic lymphocytic leukemia (CLL) at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting. With extensive long-term follow-up, the SEQUOIA study of BRUKINSA® (zanubrutinib) reinforces its role as the foundational BTK inhibitor, showing sustained disease control over years of therapy. These findings are further supported by real-world evidence across three large analyses encompassing more than 250,000 patients, underscoring consistent effectiveness and safety in clinical practice. Additionally, BEQALZI™ (sonrotoclax), which was recently approved by the U.S. Food and Drug Administration, and its development in combination with BRUKINSA (ZS) highlight the potential for next-generation, time-limited treatment approaches in CLL. Amit Agarwal, M.D., Ph.D., Chief Medical Officer, Hematology, BeOne Medicines, said: “CLL is a disease patients live with

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye